Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

NCT00922129 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study did not start up as planned.

Conditions

Prostate Cancer

Interventions

DRUG: Sirolimus (Rapamune)
DRUG: Cyclosporin (Neoral) or Tacrolimus (Prograf)

Sponsor

St. Joseph's Healthcare Hamilton